Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

NCT00407537 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1531

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Hypercholesterolemia

Interventions

DRUG: Amlodipine besylate/atorvastatin calcium single pill combination

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.